See also this year's filing and all EDGAR filings for this company.
PDF Report 0001470915_2013_Pharmagen_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001470915, Pharmagen Inc
| xvar | xval | |
|---|---|---|
| 0 | PropertyPlantAndEquipment | 90,865 |
| 1 | AssetsCurrent | 1,585,807 |
| 2 | AssetsNonCurrent | 0 |
| 3 | IntangibleAssets | 1,195,881 |
| 4 | remainder_Assets | 24,944 |
| 5 | LiabilitiesCurrent | 2,434,654 |
| 6 | LiabilitiesNonCurrent | 0 |
| 7 | remainder_Liabilities | 3,154,604 |
| 8 | GeneralAndAdministrativeExpense | 1,669,448 |
| 9 | CostOfRevenue | 0 |
| 10 | DepreciationDepletionAndAmortization | 0 |
| 11 | remainder_Expenses | 4,687,417 |
| 12 | remainder_Revenues | 3,937,234 |
| 13 | remainder_NetIncome | 323,376 |
| 14 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,897,497 |
| 1 | Liabilities | 5,589,258 |
| 2 | Expenses | 6,356,865 |
| 3 | Revenues | 3,937,234 |
| 4 | StockholdersEquity | -2,691,761 |
| 5 | NetIncome | -2,096,255 |
| 6 | ComprehensiveNetIncome | -2,096,255 |
| 7 | BaseVar | 9,552,115 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.45 |
| 9 | EconomicCapitalRatio | 0.688 |
Edgar->Model Mapping
Feature Distribution
